General Pharmaceuticals Market Research Reports & Industry Analysis
General Pharmaceuticals Industry Research & Market Reports
-
Cannabis Beverages
... CAGR of 16.3% over the analysis period 2024-2030. Non-Alcoholic Beverage, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.1 Billion by the end of the analysis ... Read More
-
Active Pharmaceutical Ingredients (API)
... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Innovative APIs, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$240.8 Billion by the ... Read More
-
Cannabis Edibles
... CAGR of 22.0% over the analysis period 2024-2030. Solid Cannabis Edibles, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$38.2 Billion by the end of the ... Read More
-
Insoluble Dietary Fibers
... at a CAGR of 8.0% over the analysis period 2024-2030. Cellulose, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Intermediate Bulk Container
... at a CAGR of 5.2% over the analysis period 2024-2030. Chemical End-Use, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$6.4 Billion by the end of ... Read More
-
Medical Marijuana
... CAGR of 14.4% over the analysis period 2024-2030. Extract Form, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$60.5 Billion by the end of the analysis ... Read More
-
Nutraceutical Excipients
... CAGR of 6.2% over the analysis period 2024-2030. Binders Functionality, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$2.4 Billion by the end of the analysis ... Read More
-
Oral Solid Dosage Forms (OSDF) and Pharma Excipients
... 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 6.2% ... Read More
-
Cannabidiol
... 14.5% over the analysis period 2024-2030. Hemp-sourced Cannabidiol, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$14.3 Billion by the end of the analysis period. Growth ... Read More
-
CBD Gummies
... CAGR of 28.8% over the analysis period 2024-2030. Low Concentration CBD Gummies, one of the segments analyzed in the report, is expected to record a 28.2% CAGR and reach US$32.4 Billion by the end of ... Read More
-
Botanical Extracts
... CAGR of 8.6% over the analysis period 2024-2030. Spices Source, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$4.8 Billion by the end of the analysis ... Read More
-
Cannabis Extract
... CAGR of 15.6% over the analysis period 2024-2030. Cannabis Oils, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$34.1 Billion by the end of the analysis ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis ... Read More
-
Latin America Halal Pharmaceuticals Market Forecast 2025-2032
... increasing demand for halal-certified healthcare products. This growth can be attributed to the region’s expanding trade relationships with Muslim-majority countries and the rise in Muslim populations within urban areas. MARKET INSIGHTS Latin American consumers, particularly ... Read More
-
Europe Halal Pharmaceuticals Market Forecast 2025-2032
... years are from 2025 to 2032. MARKET INSIGHTS The European halal pharmaceuticals market is gaining momentum, driven by the growing Muslim population and increasing awareness about ethical and religious compliance in healthcare. Countries like France, ... Read More
-
Downstream Processing
... CAGR of 15.6% over the analysis period 2024-2030. Purification Technique, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$60.6 Billion by the end of the analysis ... Read More
-
Empty Capsules
... CAGR of 5.5% over the analysis period 2024-2030. Gelatin Capsules, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$3.5 Billion by the end of the analysis ... Read More
-
Excipients
... 4.6% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.4 Billion by the end of the analysis period. Growth in ... Read More
-
Curcumin
... 8.7% over the analysis period 2024-2030. Conventional Curcumin, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$139.3 Million by the end of the analysis period. Growth ... Read More
-
Binder Excipients
... CAGR of 5.3% over the analysis period 2024-2030. Cellulosics, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.0 Billion by the end of the analysis period. ... Read More
-
Potassium Iodide
... CAGR of 6.3% over the analysis period 2024-2030. X-Ray Contrast Media End-Use, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$627.6 Million by the end of ... Read More
-
Constipation Treatment
... CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More
-
Pharmerging
... 9.7% over the analysis period 2024-2030. Pharmaceutical Pharmerging, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth ... Read More
-
Anti-Platelet Agents
... CAGR of 6.7% over the analysis period 2024-2030. Hospital Pharmacies Distribution Channel, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$2.3 Billion by the end of ... Read More
Research Assistance
